Hsp90 Inhibitors in Parasitic Nematodes: Prospects and Challenges

Eileen Devaney1, Victoria Gillan

  • 1Institute of Biodiversity, Comparative Medicine and Animal Health, University of Glasgow, Garscube Estate, Bearsden Road, Glasgow G61 1QH, UK. eileen.devaney@glasgow.ac.uk.

Insights

Heat shock protein 90 (Hsp90) inhibitors show promise for treating parasitic nematode infections. Research indicates Hsp90

Area of Science:

  • Parasitology and drug discovery
  • Molecular biology and drug repurposing

Background:

  • Heat shock protein 90 (Hsp90) inhibitors are established cancer therapeutics.
  • Hsp90 inhibitors are being explored for neurodegenerative and infectious diseases.

Purpose of the Study:

  • To discuss the repurposing of Hsp90 inhibitors for treating parasitic nematode infections.
  • To explore the potential of Hsp90 as a therapeutic target in nematodes.

Main Methods:

  • Review of existing data on Hsp90 inhibitors in parasitic diseases.
  • Analysis of Hsp90 functional diversity across nematode species.

Main Results:

  • Hsp90 exhibits functional diversity in different nematode species.
  • Hsp90 inhibitors demonstrate potential efficacy against parasitic nematodes.

Conclusions:

  • Hsp90 inhibitors represent a promising avenue for novel chemotherapeutic strategies against nematode infections.
  • Further research is needed to overcome challenges and develop Hsp90 inhibitors for nematode disease treatment.